Detalhe da pesquisa
1.
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid.
Mol Cancer
; 22(1): 178, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932736
2.
A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer.
Gynecol Oncol
; 171: 106-113, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868112
3.
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer.
Cancer Immunol Immunother
; 70(2): 519-531, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852603
4.
Distribution of novel immune-checkpoint targets in ovarian cancer tumor microenvironment: A dynamic landscape.
Gynecol Oncol
; 160(1): 279-284, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33162175
5.
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours.
Br J Cancer
; 122(4): 564-568, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31844183
6.
Tepotinib Efficacy in a Patient with Non-Small Cell Lung Cancer with Brain Metastasis Harboring an HLA-DRB1-MET Gene Fusion.
Oncologist
; 25(11): 916-920, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32716573
7.
Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT).
Gynecol Oncol
; 159(1): 129-135, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723678
8.
Corrigendum to "A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer".
Gynecol Oncol
; 175: 194, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37271667
9.
Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancer.
BJU Int
; 121(2): 203-208, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370882
10.
[Current post-surgical treatment strategies in first-line ovarian cancer]. / Stratégies thérapeutiques post-chirurgicales actuelles dans les cancers de l'ovaire en première ligne de traitement.
Bull Cancer
; 111(3): 267-276, 2024 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-36863923
11.
Spatial profiling of ovarian carcinoma and tumor microenvironment evolution under neoadjuvant chemotherapy.
Clin Cancer Res
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669064
12.
[Immunotherapy in oncogynaecology]. / Immunothérapies validées en oncogynécologie.
Bull Cancer
; 110(4): 395-401, 2023 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-36759214
13.
Targeting the immune microenvironment for ovarian cancer therapy.
Front Immunol
; 14: 1328651, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164130
14.
Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment.
Clin Cancer Res
; 29(22): 4679-4684, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699075
15.
Clinical Relevance of BRCA1 Promoter Methylation Testing in Patients with Ovarian Cancer.
Clin Cancer Res
; 29(16): 3124-3129, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067532
16.
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer.
Eur J Cancer
; 195: 113368, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897866
17.
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.
Lung Cancer
; 178: 116-122, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812760
18.
Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors.
JCO Precis Oncol
; 7: e2200583, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36862966
19.
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors.
Clin Cancer Res
; 29(21): 4504-4517, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37364000
20.
Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test.
Cells
; 11(12)2022 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35741030